Literature DB >> 27956548

A Late G1 Lipid Checkpoint That Is Dysregulated in Clear Cell Renal Carcinoma Cells.

Deven Patel1,2, Darin Salloum1,3, Mahesh Saqcena1,2, Amrita Chatterjee1,3, Victoria Mroz1, Michael Ohh4, David A Foster5,2,3,6.   

Abstract

Lipids are important nutrients that proliferating cells require to maintain energy homeostasis as well as to build plasma membranes for newly synthesized cells. Previously, we identified nutrient-sensing checkpoints that exist in the latter part of the G1 phase of the cell cycle that are dependent upon essential amino acids, Gln, and finally, a checkpoint mediated by mammalian target of rapamycin (mTOR), which integrates signals from both nutrients and growth factors. In this study, we have identified and temporally mapped a lipid-mediated G1 checkpoint. This checkpoint is located after the Gln checkpoint and before the mTOR-mediated cell cycle checkpoint. Intriguingly, clear cell renal cell carcinoma cells (ccRCC) have a dysregulated lipid-mediated checkpoint due in part to defective phosphatase and tensin homologue (PTEN). When deprived of lipids, instead of arresting in G1, these cells continue to cycle and utilize lipid droplets as a source of lipids. Lipid droplets have been known to maintain endoplasmic reticulum homeostasis and prevent cytotoxic endoplasmic reticulum stress in ccRCC. Dysregulation of the lipid-mediated checkpoint forces these cells to utilize lipid droplets, which could potentially lead to therapeutic opportunities that exploit this property of ccRCC.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  START; amino acid; cell cycle; checkpoint control; checkpoints; glutamine; lipid; lipids; mTOR complex (mTORC); renal cancer

Mesh:

Substances:

Year:  2016        PMID: 27956548      PMCID: PMC5247665          DOI: 10.1074/jbc.M116.757864

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s).

Authors:  David A Foster; Paige Yellen; Limei Xu; Mahesh Saqcena
Journal:  Genes Cancer       Date:  2010-11

2.  Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1α and HIF2α.

Authors:  Désirée Schönenberger; Sabine Harlander; Michal Rajski; Robert A Jacobs; Anne-Kristine Lundby; Mojca Adlesic; Tomas Hejhal; Peter J Wild; Carsten Lundby; Ian J Frew
Journal:  Cancer Res       Date:  2016-01-12       Impact factor: 12.701

Review 3.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

4.  Aspartate Rescues S-phase Arrest Caused by Suppression of Glutamine Utilization in KRas-driven Cancer Cells.

Authors:  Deven Patel; Deepak Menon; Elyssa Bernfeld; Victoria Mroz; Sampada Kalan; Diego Loayza; David A Foster
Journal:  J Biol Chem       Date:  2016-02-26       Impact factor: 5.157

5.  Apoptotic effects of high-dose rapamycin occur in S-phase of the cell cycle.

Authors:  Mahesh Saqcena; Deven Patel; Deepak Menon; Suman Mukhopadhyay; David A Foster
Journal:  Cell Cycle       Date:  2015-05-06       Impact factor: 4.534

6.  Rapamycin-induced G1 cell cycle arrest employs both TGF-β and Rb pathways.

Authors:  Amrita Chatterjee; Suman Mukhopadhyay; Kaity Tung; Deven Patel; David A Foster
Journal:  Cancer Lett       Date:  2015-02-03       Impact factor: 8.679

7.  Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin.

Authors:  Darin Salloum; Suman Mukhopadhyay; Kaity Tung; Aleksandra Polonetskaya; David A Foster
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

Review 8.  Amino acid regulation of TOR complex 1.

Authors:  Joseph Avruch; Xiaomeng Long; Sara Ortiz-Vega; Joseph Rapley; Angela Papageorgiou; Ning Dai
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-02       Impact factor: 4.310

9.  pVHL modification by NEDD8 is required for fibronectin matrix assembly and suppression of tumor development.

Authors:  Natalie H Stickle; Jacky Chung; Jeffery M Klco; Richard P Hill; William G Kaelin; Michael Ohh
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

10.  Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.

Authors:  Alfredo Toschi; Evan Lee; Limei Xu; Avalon Garcia; Noga Gadir; David A Foster
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

View more
  6 in total

1.  Albumin promotes the progression of fibroblasts through late G1 into S-phase in the absence of growth factors.

Authors:  Sharmeen Uddin; Nataliya Melnyk; David A Foster
Journal:  Cell Cycle       Date:  2020-07-26       Impact factor: 4.534

2.  Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin.

Authors:  Sohag Chakraborty; Matthew B Utter; Maria A Frias; David A Foster
Journal:  Cancer Lett       Date:  2021-09-23       Impact factor: 8.679

3.  Cell Cycle Progression Regulates Biogenesis and Cellular Localization of Lipid Droplets.

Authors:  André L S Cruz; Nina Carrossini; Leonardo K Teixeira; Luis F Ribeiro-Pinto; Patricia T Bozza; João P B Viola
Journal:  Mol Cell Biol       Date:  2019-04-16       Impact factor: 4.272

4.  Evidence for a Novel Regulatory Interaction Involving Cyclin D1, Lipid Droplets, Lipolysis, and Cell Cycle Progression in Hepatocytes.

Authors:  Heng Wu; Jonathan M Ploeger; Sushama Kamarajugadda; Douglas G Mashek; Mara T Mashek; Juan C Manivel; Laurie L Shekels; Jessica L Lapiro; Jeffrey H Albrecht
Journal:  Hepatol Commun       Date:  2019-01-30

Review 5.  Lipid droplets: platforms with multiple functions in cancer hallmarks.

Authors:  André L S Cruz; Ester de A Barreto; Narayana P B Fazolini; João P B Viola; Patricia T Bozza
Journal:  Cell Death Dis       Date:  2020-02-06       Impact factor: 8.469

6.  Lipid droplets: could they be involved in cancer growth and cancer-microenvironment communications?

Authors:  Polina Schwartsburd
Journal:  Cancer Commun (Lond)       Date:  2022-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.